Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx Inc (CDNA)
:CDNA
CDNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.42 - $34.84
Previous CloseN/A
Volume177.07K
Average Volume (3M)931.67K
Market Cap
$1.31B
Enterprise Value$1.44B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Feb 26, 2025EPS Estimate
-0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding53,633,870
10 Day Avg. Volume1,118,659
30 Day Avg. Volume931,675
Standard Deviation0.23
R-Squared0.18
Alpha0.00190
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.20
Price to Cash Flow (P/CF)26.20
P/FCF Ratio30.30
Enterprise Value/Market Cap1.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.08
Enterprise Value/Ebitda-36.01
Forecast
1Y Price Target
$25.00Price Target Upside1.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
CareDx News
PremiumCompany Announcements
CareDx Announces Strong Revenue Growth and Outlook
PremiumCompany Announcements
CareDx Updates Director Compensation and Vesting Policies---
Bulls Say, Bears Say
Bulls Say
EarningsRevenue grew 30% YoY in 4Q24, with $370M in revenue anticipated for 2025, suggesting continued growth momentum.
Financial PerformanceCDNA delivered $83M of revenue in Q3, matching its pre-announce and beating the Street by $3M.
Financial StabilityCareDx ended Q3 with approximately $240 million of cash and no debt, indicating financial stability and positive cash flow for the second consecutive quarter.
Bears Say
Earnings DisappointmentShares fell as investors wanted more upside to 3Q revenues and volumes, as 3Q24 revenues and test volume disappointed, with no comment on 4Q guidance.
Investment RisksInvestment risks include the failure of AlloMap and AlloSure tests to achieve commercial success due to market size, penetration rate, reimbursement, and competition.
Stock Price MovementShares of CDNA have pulled back ~20% since its analyst day.
---
Ownership Overview
8.01% Insiders
25.14% Mutual Funds
0.08% Other Institutional Investors
44.37% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDNA FAQ
What was CareDx Inc’s price range in the past 12 months?
CareDx Inc lowest stock price was $7.42 and its highest was $34.84 in the past 12 months.
What is CareDx Inc’s market cap?
CareDx Inc’s market cap is $1.31B.
When is CareDx Inc’s upcoming earnings report date?
CareDx Inc’s upcoming earnings report date is Feb 26, 2025 which is in 6 days.
How were CareDx Inc’s earnings last quarter?
CareDx Inc released its earnings results on Nov 04, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.246 by $0.106.
Is CareDx Inc overvalued?
According to Wall Street analysts CareDx Inc’s price is currently Undervalued.
Does CareDx Inc pay dividends?
CareDx Inc does not currently pay dividends.
What is CareDx Inc’s EPS estimate?
CareDx Inc’s EPS estimate is -0.41.
How many shares outstanding does CareDx Inc have?
CareDx Inc has 53,633,870 shares outstanding.
What happened to CareDx Inc’s price movement after its last earnings report?
CareDx Inc reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.246. Following the earnings report the stock price went down -0.131%.
Which hedge fund is a major shareholder of CareDx Inc?
Currently, no hedge funds are holding shares in CDNA
---
CareDx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.00 (1.21% Upside)
$25.00 (1.21% Upside)
Blogger Sentiment
Neutral
CDNA Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 579.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 7.1%
Last 30 Days ▲ 29.1%
Last 30 Days ▲ 29.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
203.81%
12-Months-Change
Fundamentals
Return on Equity
-43.02%
Trailing 12-Months
Asset Growth
-4.83%
Trailing 12-Months
Company Description
CareDx Inc
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Company Deck
---
CDNA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with strong growth metrics and achievements, such as significant revenue growth, positive EBITDA, and resolution of legal matters. However, there were some concerns about the flat revenue growth expected in Q4 and the impact of external factors like Hurricane Milton. Overall, the positive aspects outweighed the negative, showing a strong growth trajectory for CareDx.Read More>---
CDNA Stock 12 Month Forecast
Average Price Target
$25.00
▲(1.21% Upside)
Technical Analysis
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-13.31%
reiterated a buy rating 4 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -13.31% per trade.
---